Literature DB >> 15219487

Surgical therapy for acute superior mesenteric artery embolism.

Hakan Bingol1, Nazif Zeybek, Faruk Cingöz, Ahmet T Yilmaz, Harun Tatar, Derviş Sen.   

Abstract

BACKGROUND: Acute mesenteric artery embolism has a high rate of morbidity and mortality. Early diagnosis and appropriate treatment are the most important factors associated with morbidity and mortality.
METHODS: During the period between 1997 and 2002, 24 patients underwent superior mesenteric artery embolectomy. The patients were divided into three groups according to the onset of symptoms and operation time. Group I (n = 12) patients were operated on in the first 6 hours after onset of symptoms; group II (n = 9) patients were operated on between 6 and 12 hours after onset; and group III (n = 3) patients underwent embolectomy after 12 hours. Low-dose (5 to 10 mg) local tissue-type plasminogen activator (t-PA) administration directly into the superior mesenteric artery was an additional procedure with the embolectomy in all patients.
RESULTS: The macroscopic view of the intestine was normal in 15 patients (12 patients in group I and 3 patients in group II) 30 minutes after the administration of local t-PA. Segmental resection was necessary in 4 patients in group II. Extended resection was necessary in 2 patients in group II and 3 patients in group III, and all of the patients died during the early postoperative period.
CONCLUSIONS: We suggest that explorative laparotomy should be done in patients with sudden abdominal pain, nausea, vomiting, mild leukocytosis, and metabolic acidosis who have previous valvular heart disease or atrial fibrillation. Ultimately, selective low dose t-PA (5 to 10 mg) administration reduces the length of intestinal portion to be resected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219487     DOI: 10.1016/j.amjsurg.2003.10.022

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

Review 1.  Mesenteric ischemia: Pathogenesis and challenging diagnostic and therapeutic modalities.

Authors:  Aikaterini Mastoraki; Sotiria Mastoraki; Evgenia Tziava; Stavroula Touloumi; Nikolaos Krinos; Nikolaos Danias; Andreas Lazaris; Nikolaos Arkadopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  Impact of etiologic factors and APACHE II and POSSUM scores in management and clinical outcome of acute intestinal ischemic disorders after surgical treatment.

Authors:  Hui-Ping Hsu; Yan-Shen Shan; Yu-Hsiang Hsieh; Edgar D Sy; Pin-Wen Lin
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

3.  Identification of risk factors for perioperative mortality in acute mesenteric ischemia.

Authors:  Maria Asuncion Acosta-Merida; Joaquin Marchena-Gomez; Marion Hemmersbach-Miller; Cristina Roque-Castellano; Juan Maria Hernandez-Romero
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

4.  Outcome Comparison of Endovascular and Open Surgery for the Treatment of Acute Superior Mesenteric Artery Embolism: A Retrospective Study.

Authors:  Wenrui Li; Saisai Cao; Zhiwen Zhang; Renming Zhu; Xueming Chen; Bin Liu; Hai Feng
Journal:  Front Surg       Date:  2022-03-14

5.  Percutaneous mechanical thrombectomy of superior mesenteric artery embolism.

Authors:  Dimitrij Kuhelj; Pavel Kavcic; Peter Popovic
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

6.  Endovascular recanalization of occluded superior mesenteric artery using retrograde access through the inferior mesenteric artery.

Authors:  Eduardo Keller Saadi; Gustavo Oderich; Eduardo Medronha; Rodrigo Petersen Saadi; Marina Petersen Saadi; Cristiano Jaegger
Journal:  J Vasc Surg Cases Innov Tech       Date:  2017-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.